Fig. 1From: Development and validation of an LC-MS/MS method for monitoring larotrectinib, a tropomyosin-related kinase inhibitor, in mouse and human plasma and application to pharmacokinetic studiesThe structures and product-ion scan spectra of a larotrectinib and b carbamazepine (IS)Back to article page